Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
UBS
Teva
Queensland Health
US Army
QuintilesIMS
Medtronic
Chinese Patent Office
Mallinckrodt
Accenture

Generated: February 21, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,517,181

« Back to Dashboard

Summary for Patent: 4,517,181
Title: Mammalian PGRF
Abstract:PGRF has been synthesized. The invention provides synthetic peptides which are extremely potent in stimulating the release of pituitary GH in mammals and which have the formula: ##STR1## wherein R is OH or NH.sub.2, R.sub.34 is Ser or Ala, R.sub.38 is Arg or Ser, R.sub.40 is Ala or Arg and R.sub.41 is Arg, Arg-Ala, Arg-Ala-Arg, Arg-Ala-Arg-Leu or des-R.sub.41. These peptides or biologically active fragments thereof, or analogs thereof having well-known substitutions and/or additions, as well as nontoxic salts of any of the foregoing, may be administered therapeutically to mammals, including humans, and may be used diagnostically.
Inventor(s): Ling; Nicholas C. (San Diego, CA), Esch; Frederick S. (Oceanside, CA), Bohlen; Peter (Encinitas, CA), Brazeau, Jr.; Paul E. (San Diego, CA), Guillemin; Roger C. L. (La Jolla, CA)
Assignee: The Salk Institute for Biological Studies (San Diego, CA)
Application Number:06/418,248
Patent Claim Types:
see list of patent claims
Compound; Use; Composition;

Drugs Protected by US Patent 4,517,181

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 4,517,181

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 17737 ➤ Sign Up
Australia 1584383 ➤ Sign Up
Australia 548590 ➤ Sign Up
Bulgaria 37523 ➤ Sign Up
Canada 1247599 ➤ Sign Up
Czech Republic 281507 ➤ Sign Up
Czech Republic 8304357 ➤ Sign Up
German Democratic Republic 217808 ➤ Sign Up
Germany 3362003 ➤ Sign Up
Denmark 162649 ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Harvard Business School
Colorcon
Boehringer Ingelheim
UBS
Daiichi Sankyo
Argus Health
Healthtrust
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot